Literature DB >> 11926460

Health-related quality of life in patients with skull base tumours.

M O Kelleher1, M F Fernandes, D W Sim, M G O'Sullivan.   

Abstract

The objective of the investigation was to report on the health-related quality of life (HRQoL) of patients diagnosed with skull base tumours using the Short Form Health Survey questionnaire (SF-36). Those patients suffering with vestibular schwannoma were examined to determine the effect facial nerve function had on their quality of life. It took place at the tertiary referral centre at the Department of Clinical Neurosciences, Western General Hospital, Edinburgh. A prospective study of 70 consecutive patients was taken, who harboured the following tumours: 54 vestibular schwannomas, 13 meningiomas, two haemangioblastomas and one hypoglossal schwannoma. Patients were interviewed using the short form 36 (SF-36) questionnaire. Facial nerve function was assessed in those patients who had vestibular schwannomas. The entire cohort of live skull base patients were assessed after a median follow-up time of 38.4 months. Patients with vestibular schwannoma treated conservatively with interval MRI had a quality of life similar to t he normal population. Those who underwent surgery had a significant difference in two of the SF-36 domains. No statistically significant correlation was found at final assessment between the degree of facial nerve functioning and any of the domains of SF-36. Patients with non-vestibular tumours had an impaired HRQoL in seven of the eight domains. Patients with skull base tumours have a significant impairment of their HRQoL. A conservative policy of follow up with interval MRI for patients with small vestibular schwannomas may therefore be more appropriate to preserve their HRQoL. Facial nerve outcome has little influence on quality of life in vestibular schwannoma patients.

Entities:  

Mesh:

Year:  2002        PMID: 11926460     DOI: 10.1080/02688690120114183

Source DB:  PubMed          Journal:  Br J Neurosurg        ISSN: 0268-8697            Impact factor:   1.596


  8 in total

Review 1.  The clinical importance of quality-of-life scores in patients with skull base tumors: a meta-analysis and review of the literature.

Authors:  Moran Amit; Avraham Abergel; Dan M Fliss; Ziv Gil
Journal:  Curr Oncol Rep       Date:  2012-04       Impact factor: 5.075

2.  The Effect of Observation versus Microsurgical Excision on Quality of Life in Unilateral Vestibular Schwannoma: A Prospective Study.

Authors:  Dosh Sandooram; Rachael Hornigold; Beth Grunfeld; Nicholas Thomas; Neil D Kitchen; Michael Gleeson
Journal:  Skull Base       Date:  2010-01

3.  Instruments for estimation of health-related quality of life in patients with skull base neoplasms.

Authors:  Mariana E Witgert; Tracy Veramonti; Ehab Hanna
Journal:  Skull Base       Date:  2010-01

4.  Functional outcome in the neurosurgical patient and its impact on quality of life.

Authors:  Nicholas B Levine; Franco Demonte
Journal:  Skull Base       Date:  2010-01

5.  Quality of life following endonasal skull base surgery.

Authors:  Harshita Pant; Amol M Bhatki; Carl H Snyderman; Allan D Vescan; Ricardo L Carrau; Paul Gardner; Daniel Prevedello; Amin B Kassam
Journal:  Skull Base       Date:  2010-01

6.  Factors influencing quality of life in patients with benign primary brain tumors: prior to and following surgery.

Authors:  Shiow-Luan Tsay; Jui-Yen Chang; Patsy Yates; Kuan-Chia Lin; Shu-Yuan Liang
Journal:  Support Care Cancer       Date:  2010-11-24       Impact factor: 3.603

7.  A Prospective Evaluation of Quality of Life in Patients Undergoing Extended Endoscopic Endonasal Surgery for Benign Pituitary Gland Lesion.

Authors:  Narin Nard Carmel Neiderman; Anat Wengier; Omri Dominsky; Barak Ringel; Anton Warshavsky; Gilad Horowitz; Tomer Ziv Baran; Zvi Ram; Rachel Grossman; Dan Marian Fliss; Abergel Avraham
Journal:  J Neurol Surg B Skull Base       Date:  2021-05-29

8.  Quality of life after microsurgery for vestibular schwannoma via the middle cranial fossa approach.

Authors:  Matthias Scheich; Christian Ginzkey; Edith Reuter; Wilma Harnisch; Desiree Ehrmann; Rudolf Hagen
Journal:  Eur Arch Otorhinolaryngol       Date:  2013-09-06       Impact factor: 2.503

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.